Osimert is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test.
#osimert80mg #osimertinib #anticancer #antiviral #breastcancer #kidneycancer #livercancer
https://iebpharma.com/product/....osimert-80mg-osimert
Synes godt om
Kommentar
Del
